Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Insight Molecular Diagnostics (IMDX) Long-Term Debt Repayments (2020 - 2022)

Historic Long-Term Debt Repayments for Insight Molecular Diagnostics (IMDX) over the last 3 years, with Q3 2022 value amounting to $575000.0.

  • Insight Molecular Diagnostics' Long-Term Debt Repayments rose 5333.33% to $575000.0 in Q3 2022 from the same period last year, while for Dec 2022 it was $1.3 million, marking a year-over-year decrease of 1166.67%. This contributed to the annual value of $1.3 million for FY2022, which is 1166.67% down from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Long-Term Debt Repayments of $575000.0 as of Q3 2022, which was up 5333.33% from $375000.0 recorded in Q2 2022.
  • In the past 5 years, Insight Molecular Diagnostics' Long-Term Debt Repayments ranged from a high of $575000.0 in Q3 2022 and a low of $250000.0 during Q4 2020
  • For the 3-year period, Insight Molecular Diagnostics' Long-Term Debt Repayments averaged around $384375.0, with its median value being $375000.0 (2021).
  • Within the past 5 years, the most significant YoY rise in Insight Molecular Diagnostics' Long-Term Debt Repayments was 5333.33% (2022), while the steepest drop was 0.0% (2022).
  • Insight Molecular Diagnostics' Long-Term Debt Repayments (Quarter) stood at $250000.0 in 2020, then skyrocketed by 50.0% to $375000.0 in 2021, then skyrocketed by 53.33% to $575000.0 in 2022.
  • Its Long-Term Debt Repayments stands at $575000.0 for Q3 2022, versus $375000.0 for Q2 2022 and $375000.0 for Q1 2022.